These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 264783)

  • 1. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.
    Presant CA; Klahr C; Santala R
    Ann Intern Med; 1977 Jan; 86(1):47-51. PubMed ID: 264783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
    Presant CA; Kolhouse JF; Klahr C
    Cancer; 1976 Feb; 37(2):620-8. PubMed ID: 1253101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
    Presant CA; Van Amburg A; Klahr C
    Cancer; 1977 Sep; 40(3):987-93. PubMed ID: 902247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B plus 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC no. 409962) in advanced cancer. Phase I and preliminary phase II results.
    Presant CA; Klahr C; Olander J; Gatewood D
    Cancer; 1976 Nov; 38(5):1917-21. PubMed ID: 991105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
    Presant CA; Klahr C
    Cancer; 1978 Sep; 42(3):1222-7. PubMed ID: 698913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
    Presant CA; Hillinger S; Klahr C
    Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma.
    Krutchik AN; Buzdar AU; Blumenschein GR; Sinkovics JG
    Cancer Treat Rep; 1978 Oct; 62(10):1565-7. PubMed ID: 709557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovary.
    Presant CA; Bartolucci A
    Med Pediatr Oncol; 1983; 11(3):151-3. PubMed ID: 6682929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency.
    Medoff G; Valeriote F; Ryan J; Tolen S
    J Natl Cancer Inst; 1977 Apr; 58(4):949-53. PubMed ID: 845998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Valeriote F; Lynch R; Medoff G; Tolen S; Dieckman J
    J Natl Cancer Inst; 1978 Aug; 61(2):399-402. PubMed ID: 277727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Kyle RA; Pajak TF; Henderson ES; Nawabi IU; Brunner K; Henry PH; McIntyre OR; Holland JF
    Cancer Treat Rep; 1982 Mar; 66(3):451-6. PubMed ID: 7060034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.
    Ghanta VK; Jones MT; Woodard DA; Durant JR; Hiramoto RN
    Cancer Res; 1977 Mar; 37(3):771-4. PubMed ID: 851480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancer.
    Ahmann DL; Carr DT; Coles DT; Hahn RG
    Cancer Chemother Rep; 1972 Jun; 56(3):401-3. PubMed ID: 19051501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrosoureas in multiple myeloma.
    Salmon SE
    Cancer Treat Rep; 1976 Jun; 60(6):789-94. PubMed ID: 782701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for multiple myeloma.
    Alexanian R; Salmon S; Bonnet J; Gehan E; Haut A; Weick J
    Cancer; 1977 Dec; 40(6):2765-71. PubMed ID: 589554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin plus alkylating agents in the treatment of metastatic breast cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Henderson IC; Blum RH; Frei E
    Cancer; 1977 Dec; 40(6):2801-5. PubMed ID: 338136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
    Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS
    Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
    Alberts DS; Durie BG; Salmon SE
    Lancet; 1976 May; 1(7966):926-8. PubMed ID: 57335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
    Presant CA; Ratkin G; Klahr C; Brown C
    Cancer; 1979 Nov; 44(5):1571-5. PubMed ID: 227570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.